Rosoxacin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Rosoxacin
Rosoxacin.svg
Systematic (IUPAC) name
1-Ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
?
Identifiers
CAS number 40034-42-2 YesY
ATC code J01MB01
PubChem CID 287180
DrugBank DB00817
ChemSpider 253208 N
UNII 3Y1OT3J4NW N
KEGG D02305 N
ChEMBL CHEMBL291157 N
Chemical data
Formula C17H14N2O3 
Mol. mass 294.30 g/mol
Physical data
Melt. point 290 °C (554 °F)
 N (what is this?)  (verify)

Rosoxacin (also known as acrosoxacin, tradename Eradacil) is a quinolone antibiotic indicated for the treatment of urinary tract infections and certain sexually transmitted diseases. Rosoxacin is not available in the United States.

It was developed by Sanofi-Synthelabo (now part of sanofi-aventis).

It is classified as first generation.[1]

See also[edit]

References[edit]

  1. ^ Przybilla B, Georgii A, Bergner T, Ring J (1990). "Demonstration of quinolone phototoxicity in vitro". Dermatologica 181 (2): 98–103. doi:10.1159/000247894. PMID 2173670.